Guangdong Jiaying Pharmaceutical Co., Ltd. Class A

As of June 30, 2026, Guangdong Jiaying Pharmaceutical Co., Ltd. Class A carries a market capitalization of 1.54B, placing it among publicly traded companies globally. Its enterprise value stands at 1.43B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Guangdong Jiaying Pharmaceutical Co., Ltd. Class A has 507.51M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Guangdong Jiaying Pharmaceutical Co., Ltd. Class A maintains a current ratio of 4.58, meaning it holds 4.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Guangdong Jiaying Pharmaceutical Co., Ltd. Class A recorded 4.51M in income tax expense.

As of the close on October 23, 2026, Guangdong Jiaying Pharmaceutical Co., Ltd. Class A's stock has declined approximately 50.23% over the past 52 weeks. The 50-day moving average sits at 3.51, while the 200-day moving average is 5.16.

As of June 30, 2026, Guangdong Jiaying Pharmaceutical Co., Ltd. Class A holds 128.45M in cash and equivalents against 20.00M in total debt, resulting in a net debt position of -105.23M. Total book value stands at 704.88M, with working capital of 385.11M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Guangdong Jiaying Pharmaceutical Co., Ltd. Class A's most recent stock split took place on April 3, 2014 with a 1:2 split ratio.